Stocks to Buy August 2015 on Investment News Show

undervalued medical stocks to buy

The August 4th show features a live interview with:

Immune Therapeutics Inc.

(Stock Symbol: IMUN),

CEO Noreen Griffin,

Dr Jay Ellenby and

Dr Gloria Herndon

small cap medical stock

Visit The Corporate Site — ImmuneTherapeutics.com

See Corporate Investors Information and stock quote page:
Click Here

Listen To Show Replay Part 1:

 

Listen To Show Replay Part 2 with Immune Therapeutics Interview:

 

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.

Small Cap Stocks to Buy August 2015

LDN (Low Dose Naltrexone)

Low Dose Naltrexone used as an immune modulator

Low Dose Naltrexone as it is known in the United States, or Lodonal as it is known internationally, has its origins in the FDA approved 50mg Naltrexone. Originally used to treat opiate dependences, the Immune Therapeutics patented treatments, which cover a wide range of indications (link to LDN patents), is currently used as an immune modulator.

See Report  — Click Here

Medical Stocks to Buy August 2015

The biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy.

Their Products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

undervalued medical Stocks to Buy August 2015

Small Cap Medical Stock News

Partnership with GB Pharma and AHAR sign LOI with Fidson Healthcare Plc for the distribution of Lodonal in Nigeria Announced.

Immune Therapeutics Inc. in partnership with GB Pharma Holdings Inc and American Hospitals & Resort [AHAR], announces that they have signed a Letter of Intent with Nigerian public company, Fidson Healthcare Plc [NSE:FIDSON.LG] one of Nigeria’s leading pharmaceutical companies. — See News

 

Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS

Immune Therapeutics Inc. through its fully owned subsidiary, TNI Biotech International, today announced the dosing of the first patient with Lodonal™ (Once-daily Oral Treatment) for the 90-Day bridging clinical trial of Immune Therapeutics’ proprietary patented therapy (Lodonal™) as an adjunct  treatment for HIV/AIDS and opportunistic infections. — See More

best Stocks to Buy August 2015

Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News

 

Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News

 

MoneyInfo Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show

LISTEN LIVE

Use this Link To Watch The Show:

www.princetonresearch.com/money-info-live.htm

Be On The Air With Us
Call In Your Questions
888-792-1590

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

The show is broadcast live on the internet and on the air  from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast 

Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.

Small cap stocks to buy

Stocks to Buy August 2015 on Investment News Show